Home
>
National Drug Code (NDC)
>
ELOXATIN
ELOXATIN - 0024-0591-20 - (oxaliplatin)
Drug Information of ELOXATIN
| Product NDC: | 0024-0591 |
| Proprietary Name: | ELOXATIN |
| Non Proprietary Name: | oxaliplatin |
| Active Ingredient(s): | 100 mg/1 & nbsp; oxaliplatin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ELOXATIN
| Product NDC: | 0024-0591 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021759 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060602 |
Package Information of ELOXATIN
| Package NDC: | 0024-0591-20 |
| Package Description: | 1 INJECTION, SOLUTION, CONCENTRATE in 1 CARTON (0024-0591-20) |
NDC Information of ELOXATIN
| NDC Code | 0024-0591-20 |
| Proprietary Name | ELOXATIN |
| Package Description | 1 INJECTION, SOLUTION, CONCENTRATE in 1 CARTON (0024-0591-20) |
| Product NDC | 0024-0591 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxaliplatin |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20060602 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | OXALIPLATIN |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
